drugset / Trial / NCT03714568
Pharmacokinetic and Tolerance Study of TQ-A3326 in Healthy Participants.
RandomizedParallel-groupQuadruple-blindOther
Summary
To study the single dose and multi-doses pharmacokinetic characteristics and tolerance of TQ-A3326 in the human body；To study the transformation of TQ-A3326；To study the effect of the food on the pharmacokinetic characteristics of TQ-A3326.
Timeline
- Start
- 2018-11-11
- Primary completion
- 2019-09
- Completion
- 2019-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TQ-A3326 | Unknown | 15 mg | Oral |
| Subject | TQ-A3326 | Unknown | 60 mg | Oral |
| Subject | TQ-A3326 | Unknown | 180 mg | Oral |
Indications
No indication recorded.